StonvexLoading…
StonvexStonvexStonvexCore line items from HDB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $25.64B | $22.24B | $13.76B | $11.76B |
Operating Income | $10.08B | $8.46B | $8.06B | $6.84B |
Net Income | $7.88B | $7.47B | $6.03B | $5.09B |
EPS (Diluted) | $1.04 | $1.05 | $1.07 | $0.91 |
Total Assets | $564.06B | $529.38B | $313.37B | $278.29B |
Total Liabilities | $463.13B | $434.75B | $277.87B | $245.21B |
Cash & Equivalents | $23.21B | $24.42B | $16.65B | $13.65B |
Free Cash Flow OCF − CapEx | $13.22B | $11.62B | $5.28B | $7.31B |
Shares Outstanding | 7.65B | 7.60B | 5.58B | 5.55B |